Thursday, 28 August 2008

Early Diagnosis For Osteoarthritis

�A freshly developed medical imaging technology may provide doctors with a long-awaited test for early diagnosing of degenerative arthritis (OA), scientists from New York reported at the 236th National Meeting of the American Chemical Society. By far the well-nigh common cast of arthritis, OA is a curse of the Baby Boom generation, causing joint pain and disablement for more than than half of those over 65 - intimately 21 jillion people in the United States.



Current diagnostic methods usually do not catch the disease until OA is in modern stages when joint terms may already have occurred. A method for early diagnosis could open a window of opportunity for preventing or reducing permanent damage - especially with evidence that dietary supplements like glucosamine and chondroitin can block further joint degeneration, says Alexej Jerschow, Ph.D., wHO reported on the inquiry jointly with Ravinder R. Regatte, Ph.D.



"Our methods sustain the potential difference of providing early word of advice signs for cartilage disorders like degenerative joint disease, thus potentially avoiding surgical procedure and physical therapy later on," states Jerschow. "Also, the effectiveness of early preventative do drugs therapies throne be better assessed with these methods."



Especially common in the stifle and hip, osteoarthritis amends cartilage, the tough, elastic material that cushions moving parts of joints. OA is the most common reason for total hip and add up knee replacement surgery. "It has all these atrocious consequences and makes it difficult to move - it results in a severe exit of quality of life for those who are affected by it," says Regatte.



The newfangled method uses a modified form of magnetic rapport imaging to determine the concentration of a polymer known as glycosaminogycan (GAG) that holds lots of water and gives gristle its ruffianly, elastic properties. GAG besides is a recognized biomarker for both osteoarthritis and degenerative platter disease - a vulgar cause of back painful sensation. According to Jerschow, a low denseness of GAG is known to correlate with the onset of osteoarthritis and other cartilage disorders.



The diagnostic "tags" the hydrogen atoms attached to the GAGs in a way that makes them emit a signal that can be picked up by an MRI automobile to determine the assiduousness of GAG and assess cartilage health.



Advanced OA is very soft to diagnose, Regatte points out. By then, still, joint surrogate may be the only option. With early sleuthing, physicians could prescribe dietary supplements, medicinal drug or other measures to ward off further gristle damage.



"Given the lack of knowledge about OA, I think whatever method that is noninvasive and relatively easy to apply will be quite valuable. Not only do you address diagnosis, simply you address how we can empathize OA's mechanism," says Jerschow.



The test could also be used to improve existing cartilage-boosting drugs, Regatte says. Currently, it's difficult to gauge the efficacy of these drugs without a diagnostic creature to measure their effects on cartilage.



"There are drugs on the market for OA discussion, but no one really knows how effective they are. After having done the inquiry, we got a lot of calls from pharmaceutic companies missing to show that their drugs work," says Jerschow.



The cost and time it takes for the gristle test is practically the same as a normal MRI, states Regatte. Diagnosis could be given on a same day basis.



"I really leslie Townes Hope it will develop into the gold standard technique," says Jerschow. "I'm pretty confident in saying that its ane of the better methods out in that respect for testing cartilage health."





Adam Dylewski



The American Chemical Society - the world's largest scientific high society - is a nonprofit organization organization hired by the U.S. Congress and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.



Source:

Charmayne Marsh

Michael Bernstein
American Chemical Society



More info